Therapeutic Targeting of Follicular T Cells with Chimeric Antigen Receptor-Expressing Natural Killer Cells (vol 1, pg 100003, 2020)

被引:0
|
作者
Reighard, Seth D.
Cranert, Stacey A.
Rangel, Kelly M.
Ali, Ayad
Gyurova, Ivayla E.
de la Cruz-Lynch, Arthur T.
Tuazon, Jasmine A.
Khodoun, Marat V.
Kottyan, Leah C.
Smith, David F.
Brunner, Hermine I.
Waggoner, Stephen N.
机构
关键词
D O I
10.1016/j.xcrm.2020.100080
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
引用
收藏
页数:3
相关论文
共 50 条
  • [41] Natural killer cell receptor-expressing innate lymphocytes: more than just NK cells
    Mortha, Arthur
    Diefenbach, Andreas
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2011, 68 (21) : 3541 - 3555
  • [42] Natural killer cell receptor-expressing innate lymphocytes: more than just NK cells
    Arthur Mortha
    Andreas Diefenbach
    Cellular and Molecular Life Sciences, 2011, 68 : 3541 - 3555
  • [43] Targeting epidermal growth factor-overexpressing triple-negative breast cancer by natural killer cells expressing a specific chimeric antigen receptor
    Liu, Yan
    Zhou, Yehui
    Huang, Kuo-Hsiang
    Fang, Xujie
    Li, Ying
    Wang, Feifei
    An, Li
    Chen, Qingfei
    Zhang, Yunchao
    Shi, Aihua
    Yu, Shuang
    Zhang, Jingzhong
    CELL PROLIFERATION, 2020, 53 (08)
  • [44] The transfection of natural killer T cells with a tumor-antigen specific chimeric antigen receptor (CAR) for melanoma immunotherapy
    Simon, B.
    Wiesinger, M.
    Maerz, J.
    Wistuba-Hamprecht, K.
    Weide, B.
    Schuler-Thurner, B.
    Schuler, G.
    Doerrie, J.
    Uslu, U.
    EXPERIMENTAL DERMATOLOGY, 2019, 28 (03) : E56 - E57
  • [45] Immunotherapeutic Targeting of TSLPR with Chimeric Antigen Receptor T Cells in AML
    Call, Lindsey F.
    Castro, Sommer
    Tang, Thao T.
    Nourigat-Mckay, Cynthia
    Perkins, LaKeisha
    Pardo, Laura
    Leonti, Amanda R.
    Meshinchi, Soheil
    Le, Quy
    BLOOD, 2021, 138
  • [46] Tumor-targeting domains for chimeric antigen receptor T cells
    Bezverbnaya, Ksenia
    Mathews, Ashish
    Sidhu, Jesse
    Helsen, Christopher W.
    Bramson, Jonathan L.
    IMMUNOTHERAPY, 2017, 9 (01) : 33 - 46
  • [47] Different stimulation conditions affect the immune phenotype of GD2-specific chimeric antigen receptor-expressing T cells
    Ochs, Laurin
    Altvater, Bianca
    Kailayangiri, Sareetha
    Spurny, Christian
    Rossig, Claudia
    Jamitzky, Silke
    CANCER RESEARCH, 2016, 76
  • [48] TARGETING MET WITH CHIMERIC ANTIGEN RECEPTOR T CELLS IN HEPATOCELLULAR CARCINOMA
    Qin, Yuan
    Qin, Anna
    Musket, Anna
    Lee, Joseph
    Yao, Zhi
    Krenciute, Giedre
    Xie, Qian
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A82 - A83
  • [49] Targeting Cancer Stem Cells by Genetically Engineered Chimeric Antigen Receptor T Cells
    Alhabbab, Rowa Y.
    FRONTIERS IN GENETICS, 2020, 11
  • [50] Chimeric NKG2D receptor-expressing T cells as an immunotherapy for multiple myeloma
    Barber, Amorette
    Zhang, Tong
    Megli, Christina J.
    Wu, Jillian
    Meehan, Kenneth R.
    Sentman, Charles L.
    EXPERIMENTAL HEMATOLOGY, 2008, 36 (10) : 1318 - 1328